{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:07:18Z","timestamp":1783012038987,"version":"3.54.6"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Biologica Hungarica"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1556\/abiol.63.2012.4.8","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T02:08:05Z","timestamp":1352340485000},"page":"490-500","source":"Crossref","is-referenced-by-count":5,"title":["<i>In vitro<\/i>interactions of amantadine hydrochloride, R-(-)-deprenyl hydrochloride and valproic acid sodium salt with antifungal agents against filamentous fungal species causing central nervous system infection"],"prefix":"10.1007","volume":"63","author":[{"given":"L.","family":"Galg\u00f3czy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili\u00e1na","family":"T\u00f3th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vir\u00e1gh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Papp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cs.","family":"V\u00e1gv\u00f6lgyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0732-8893(98)00102-3","article-title":"In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B","volume":"33","author":"Abraham O. C.","year":"1999","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10096-003-0947-x","article-title":"Antifungal activity of nonantifungal drugs","volume":"22","author":"Afeltra J.","year":"2003","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"3","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1177\/0091270007304779","article-title":"Pharmacokinetics and absolute bioavailability of selegiline following treatment of healthy subjects with the selegiline transdermal system (6 mg\/24 h): a comparison with oral selegiline capsules","volume":"47","author":"Azzaro A. J.","year":"2007","journal-title":"J. Clin. Pharmacol."},{"key":"4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1034\/j.1399-0012.2002.02033.x","article-title":"Fungal brain abscess in transplant recipients: epidemiologic, microbiologic, and clinical features","volume":"16","author":"Baddley J. W.","year":"2002","journal-title":"Clin. Transplant."},{"key":"5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00213-005-0272-4","article-title":"Valproic acid selectively inhibits conversion of arachidonic acid to arachidonoyl-CoA by brain microsomal long-chain fatty acyl-CoA synthetases: relevance to bipolar disorder","volume":"184","author":"Bazinet R. P.","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"6","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/AAC.01280-07","article-title":"Potential basis for amphotericin B resistance in Aspergillus terreus","volume":"52","author":"Blum G.","year":"2008","journal-title":"Antimicrob. Agents. Chemother."},{"key":"7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mycmed.2006.02.001","article-title":"Brain abscess due to Aspergillus nidulans","volume":"16","author":"Chakrabarti A.","year":"2005","journal-title":"J. Mycol. Med."},{"key":"8","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/archneur.1989.00520420096030","article-title":"Amantadine treatment of fatigue associated with multiple sclerosis","volume":"46","author":"Cohen R. A.","year":"1989","journal-title":"Arch. Neurol."},{"key":"9","first-page":"CD003468","article-title":"Amantadine in Parkinson\u2019s disease","volume":"1","author":"Crosby N.","year":"2003","journal-title":"Cochrane Database Syst. Rev."},{"key":"10","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/jac\/44.4.553","article-title":"In-vitro susceptibility of Aspergillus spp. isolates to amphotericin B and itraconazole","volume":"44","author":"Dannaoui E.","year":"1999","journal-title":"J. Antimicrob. Chemother."},{"key":"11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/dkg020","article-title":"In vitro susceptibilities of zygomycetes to conventional and new antifungals","volume":"51","author":"Dannaoui E.","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/518936","article-title":"Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide","volume":"196","author":"Deyde V. M.","year":"2007","journal-title":"J. Infect. Dis."},{"key":"13","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/0028-3886.35681","article-title":"Immunopathogenesis of central nervous system fungal infections","volume":"55","author":"Dotis J.","year":"2007","journal-title":"Neurol. India"},{"key":"14","volume-title":"Antibiotics in Laboratory Medicine, 4th edn","author":"Eliopoulos G. M.","year":"1996"},{"key":"15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12281-010-0016-8","article-title":"Antifungal distribution into cerebrospinal fluid, vitreous humor, bone, and other difficult sites","volume":"4","author":"Eltoukhy N. S.","year":"2010","journal-title":"Curr. Fungal. Infect. Rep."},{"key":"16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1517\/14656566.4.2.147","article-title":"Antifungal pharmacotherapy for invasive mould infections","volume":"4","author":"Gallagher C. G.","year":"2003","journal-title":"Expert Opin. Pharm."},{"key":"17","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1093\/jac\/dkh228","article-title":"In vitro activity of terbinafine against medically important non-dermatophyte species of filamentous fungi","volume":"53","author":"Garcia-Effron G.","year":"2004","journal-title":"J. Antimicrob. Chemother"},{"key":"18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0732-8893(02)00509-6","article-title":"In vitro evaluation of combination of terbinafine with itraconazole or amphotericin B against Zygomycota","volume":"45","author":"G\u00f3mez-L\u00f3pez A.","year":"2003","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/315643","article-title":"Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system","volume":"182","author":"Groll A. H.","year":"2000","journal-title":"J. Infect. Dis."},{"key":"20","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/jps.1132","article-title":"Tissue distribution of terbinafine in rats","volume":"90","author":"Hosseini-Yeganeh M.","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"21","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1128\/AAC.46.7.2219-2228.2002","article-title":"Physiologically based pharmacokinetic model for terbinafine in rats and humans","volume":"46","author":"Hosseini-Yeganeh M.","year":"2002","journal-title":"Antimicrob. Agents. Chemother."},{"key":"22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1124\/dmd.31.3.319","article-title":"Effect of efflux inhibition on brain uptake of itraconazole in mice infected with Cryptococcus neoformans","volume":"31","author":"Imbert F.","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"23","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1439-0507.2004.00988.x","article-title":"In vitro activity of terbinafine and itraconazole against Aspergillus species isolated from otomycosis","volume":"47","author":"Karaarslan A.","year":"2004","journal-title":"Mycoses."},{"key":"24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1046\/j.1439-0507.2002.00797.x","article-title":"Aspergillus nidulans is frequently resistant to amphotericin B","volume":"45","author":"Kontoyiannis D. P.","year":"2002","journal-title":"Mycoses."},{"key":"25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/0028-3908(95)00056-C","article-title":"Therapeutic brain concentration of the NMDA receptor antagonist amantadine","volume":"34","author":"Kornhuber J.","year":"1995","journal-title":"Neuropharmacology."},{"key":"26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.pnpbp.2006.11.019","article-title":"Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells","volume":"31","author":"Kurita M.","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00003088-199733020-00002","article-title":"Clinical pharmacokinetics and pharmacodynamics of selegiline. An update","volume":"33","author":"Mahmood I.","year":"1997","journal-title":"Clin. Pharmacokinet."},{"key":"28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ijantimicag.2006.07.011","article-title":"The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions","volume":"28","author":"Meletiadis J.","year":"2006","journal-title":"Int. J. Antimicrob. Agents."},{"key":"29","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/j.1469-0691.2003.00755.x","article-title":"In vitro activity of ravuconazole against Zygomycetes, Scedosporium and Fusarium isolates","volume":"9","author":"Minassian B.","year":"2003","journal-title":"Clin. Microbiol. Infect."},{"key":"30","doi-asserted-by":"crossref","first-page":"112","DOI":"10.4103\/0377-4929.77352","article-title":"Comparison of the activities of amphotericin B, itraconazole, and voriconazole against clinical and environmental isolates of Aspergillus species","volume":"54","author":"Misra R.","year":"2011","journal-title":"Indian. J. Pathol. Microbiol."},{"key":"31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/jac\/49.1.209","article-title":"Resistance to amphotericin B does not emerge during treatment for invasive aspergillosis","volume":"49","author":"Moosa M. Y.","year":"2002","journal-title":"J. Antimicrob. Chemother."},{"key":"32","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1094\/PHYTO.2003.93.11.1344","article-title":"Activity of the antifungal protein from Aspergillus giganteus against Botrytis cinerea","volume":"93","author":"Moreno A. B.","year":"2003","journal-title":"Phytopathology"},{"key":"33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/0028-3886.35682","article-title":"Fungal infections of the central nervous system: the clinical syndromes","volume":"55","author":"Murthy J. M.","year":"2007","journal-title":"Neurol. India"},{"key":"34","first-page":"S37","article-title":"Aspergilloma of the brain: an overview","volume":"51","author":"Nadkarni T.","year":"2005","journal-title":"J. Postgrad. Med."},{"key":"35","volume-title":"NCCLS document M38-A","year":"2002"},{"key":"36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/157489106775244109","article-title":"Current status and future of antifungal therapy for systemic mycoses","volume":"1","author":"Nosanchuk J. D.","year":"2006","journal-title":"Recent Pat. Antiinfect. Drug Discov."},{"key":"37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg301","article-title":"Synergy, antagonism, and what the chequerboard puts between them","volume":"52","author":"Odds F. C.","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"38","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/jac\/41.5.567","article-title":"Susceptibility of Aspergillus strains from culture collections to amphotericin B and itraconazole","volume":"41","author":"Rath P. M.","year":"1998","journal-title":"J. Antimicrob. Chemother."},{"key":"39","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CMR.13.2.236-301.2000","article-title":"Zygomycetes in human disease","volume":"13","author":"Ribes J. A.","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"40","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1128\/AAC.00163-06","article-title":"In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts","volume":"50","author":"Sabatelli F.","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1439-0507.2007.01345.x","article-title":"Poor efficacy of amphotericin B-based therapy in CNS aspergillosis","volume":"50","author":"Schwartz S.","year":"2007","journal-title":"Mycoses."},{"key":"42","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1080\/13693780802537953","article-title":"Cerebral aspergillosis: tissue penetration is the key","volume":"47","author":"Schwartz S.","year":"2009","journal-title":"Med. Mycol."},{"key":"43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/WCO.0b013e3282fee95b","article-title":"Fungal brain infections","volume":"21","author":"Scully E. P.","year":"2008","journal-title":"Curr. Opin. Neurol."},{"key":"44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.ijsu.2010.07.293","article-title":"Fungal infections of the nervous system: current perspective and controversies in management","volume":"8","author":"Sharma R.R.","year":"2010","journal-title":"Int. J. Surg."},{"key":"45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1469-0691.2009.02980.x","article-title":"Disseminated zygomycosis with involvement of the central nervous system","volume":"15","author":"Skiada A.","year":"2009","journal-title":"Clin. Microbiol. Infect."},{"key":"46","first-page":"328","article-title":"Pharmacokinetics of antifungals: Implications for drug selections","volume":"23","author":"Smith J.","year":"2006","journal-title":"Infect. Med."},{"key":"47","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.46.5.1581-1582.2002","article-title":"In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes","volume":"46","author":"Sun Q. N.","year":"2002","journal-title":"Antimicrob. Agents. Chemother."},{"key":"48","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1128\/JCM.37.7.2343-2345.1999","article-title":"In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole","volume":"37","author":"Sutton D. A.","year":"1999","journal-title":"J. Clin. Microbiol."},{"key":"49","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1086\/597465","article-title":"Azole-resistant central nervous system aspergillosis","volume":"48","author":"Linden J. W.","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"50","doi-asserted-by":"crossref","first-page":"115","DOI":"10.2217\/17460913.2.2.115","article-title":"Combination antifungal therapy: the new frontier","volume":"2","author":"Vazquez J. A.","year":"2007","journal-title":"Future Microbiol."},{"key":"51","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/j.1439-0507.2008.01536.x","article-title":"Rhino-cerebral zygomycosis resistant to antimycotic treatment: a case report","volume":"52","author":"Vyzantiadis T. A.","year":"2002","journal-title":"Mycoses."},{"key":"52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/jpet.105.096263","article-title":"Metabolic transformation plays a primary role in the psychostimulant-like discriminative-stimulus effects of selegiline [(R)-(-)-deprenyl]","volume":"317","author":"Yasar S.","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Acta Biologica Hungarica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.akademiai.com\/doi\/pdf\/10.1556\/abiol.63.2012.4.8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,15]],"date-time":"2020-07-15T19:27:09Z","timestamp":1594841229000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.akademiai.com\/doi\/abs\/10.1556\/ABiol.63.2012.4.8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["10.1556\/ABiol.63.2012.4.8"],"URL":"https:\/\/doi.org\/10.1556\/abiol.63.2012.4.8","relation":{},"ISSN":["0236-5383","1588-256X"],"issn-type":[{"value":"0236-5383","type":"print"},{"value":"1588-256X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}